Entropy Technologies LP Invests $226,000 in Addus HomeCare Co. (NASDAQ:ADUS)

Entropy Technologies LP bought a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS) during the third quarter, Holdings Channel reports. The fund bought 1,696 shares of the company’s stock, valued at approximately $226,000.

Other hedge funds have also modified their holdings of the company. UMB Bank n.a. lifted its stake in Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after buying an additional 88 shares in the last quarter. Quest Partners LLC purchased a new position in shares of Addus HomeCare in the second quarter worth approximately $31,000. EntryPoint Capital LLC acquired a new stake in shares of Addus HomeCare during the first quarter valued at approximately $44,000. Innealta Capital LLC purchased a new stake in shares of Addus HomeCare in the 2nd quarter valued at approximately $44,000. Finally, Farther Finance Advisors LLC boosted its stake in Addus HomeCare by 9,150.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after purchasing an additional 366 shares during the period. 95.35% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. Royal Bank of Canada restated an “outperform” rating and issued a $136.00 target price on shares of Addus HomeCare in a report on Thursday. Oppenheimer raised their price objective on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. TD Cowen upped their target price on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a report on Thursday, August 8th. KeyCorp assumed coverage on shares of Addus HomeCare in a report on Friday, October 11th. They set an “overweight” rating and a $150.00 price target for the company. Finally, Macquarie reaffirmed an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Addus HomeCare has a consensus rating of “Moderate Buy” and a consensus price target of $131.63.

Insiders Place Their Bets

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. This trade represents a 75.23 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total transaction of $65,015.00. Following the completion of the transaction, the director now directly owns 3,866 shares in the company, valued at approximately $502,695.98. This represents a 11.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 22,917 shares of company stock valued at $3,050,082 over the last quarter. Insiders own 4.60% of the company’s stock.

Addus HomeCare Stock Performance

NASDAQ:ADUS opened at $119.78 on Friday. The company has a market capitalization of $2.17 billion, a P/E ratio of 27.41, a P/E/G ratio of 2.15 and a beta of 1.04. The stock’s 50 day moving average price is $128.99 and its 200 day moving average price is $122.42. Addus HomeCare Co. has a 52 week low of $85.43 and a 52 week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. The business had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Addus HomeCare’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter last year, the firm earned $1.03 EPS. As a group, sell-side analysts forecast that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.